Income statement, balance sheet and cash flow statement for the last 6 fiscal years, taken from the XBRL data Nextel Medical Corp. files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
FY2010
FY2012
FY2012
FY2019
FY2019
FY2020
Revenue
0
0
0
0
0
General and administrative
0.03
1.01
0
0.13
0.47
Operating expenses
0.1
5.99
0
0.13
0.47
Operating income
-0.1
-5.99
-0
-0.13
-0.47
Interest expense
0.01
0.08
0
0
Other non-operating income
-0.01
-0.08
0
0.03
Pre-tax income
-0
-0.13
-0.44
Income tax
0
0
0
Net income
-0.01
-0.1
-6.07
-0
-0.13
-0.44
EPS, basic
0.00
-0.09
0.00
0.00
0.00
EPS, diluted
0.00
-0.09
0.00
0.00
0.00
Shares, basic (weighted)
83.8
67.2
114
250
250
Shares, diluted (weighted)
83.8
67.2
114
250
250
Balance sheet
FY2010
FY2012
FY2012
FY2019
FY2019
FY2020
Cash and equivalents
0
0.07
0.01
0
0
0
Other current assets
0
0.06
Total current assets
0.07
0.01
0
0
0.06
Total assets
0.07
0.01
0
0
0.06
Accounts payable
0.03
0.08
0.08
0.13
0.2
Accrued liabilities
0.01
0.01
0.08
0
Total current liabilities
0.1
0.28
0.09
0.21
0.44
Total liabilities
0.1
0.28
0.09
0.21
0.44
Paid-in capital
-0.02
5.8
8.18
8.18
8.45
Retained earnings
-0.11
-6.18
-8.52
-8.65
-9.08
Shareholders' equity
-0.01
-0.03
-0.27
-0.09
-0.21
-0.39
Total equity
-0.01
-0.03
-0.27
-0.09
-0.21
-0.39
Total liabilities and equity
0.07
0.01
0
0
0.06
Shares outstanding
97.5
48.8
250
250
250
Cash flow statement
FY2010
FY2012
FY2012
FY2019
FY2019
FY2020
Net income
-0.01
-0.1
-6.07
-0
-0.13
-0.44
Stock-based compensation
0.82
Change in payables
0.04
0.06
0
0.05
0.21
Cash from operations
-0.06
-0.22
-0
-0.01
-0.17
Cash from investing
0
0
0
0
Stock issued
0.08
Cash from financing
0.13
0.15
0
0.01
0.17
Net change in cash
0.07
-0.07
-0
-0
0
Interest paid
0
0
0
0
0
Income taxes paid
0
0
0
0
Key metrics
Worked out from the statements above. Latest values use the trailing twelve months to July 31, 2020; growth uses fiscal years. Valuation uses the share price of $0.01 on September 25, 2026.
Profitability
Metric
Value
How it is calculated
Return on assets (ROA)
-51,829.0%
Net income / average total assets.
Growth
Metric
Value
How it is calculated
Share count change, 1y
0.0%
Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Balance sheet health
Metric
Value
How it is calculated
Current ratio
0.00x
Current assets / current liabilities.
Quick ratio
0.00x
(Cash + short-term investments + receivables) / current liabilities.
Cash ratio
0.00x
(Cash + short-term investments) / current liabilities.
Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share
$0.00
Revenue / diluted weighted shares.
Operating cash flow per share
-$0.00
Cash from operations / diluted weighted shares.
Book value per share
-$0.00
Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Market cap + total debt - cash - short-term investments.
Earnings yield
-41.5%
Net income / market cap (the inverse of P/E).
What was Nextel Medical Corp.'s revenue in fiscal 2020?
Nextel Medical Corp. reported revenue of $0.0 for fiscal 2020.
Was Nextel Medical Corp. profitable in fiscal 2020?
No. It reported a net loss of $436.0K.
Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.